Trade Mark 2626851 | IP Australia

Advanced search

Number: 2626851

IR number: 1901994

Words: AMPA-VEGA
Image description: MOLECULAR-DIAGRAM
Status: protected: Registered/protected
Priority date: 11 Jul 2025 (Convention)
Classes: 42, 44
Kind: Figurative

Goods & Services

Class 42:: Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders.

Class 44:: Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders.

Endorsements

The mark consists of an open circle from which extend six lines ending in filled circles, all in blue. Below that appears the wording AMPA-VEGA, with AMPA and VEGA appearing in dark navy blue and the hyphen appearing in blue.

The color(s) blue and dark navy blue is/are claimed as a feature of the mark.

Convention details

Date:

11 Jul 2025

Number:

99278648

Country:

UNITED STATES OF AMERICA

Opposition details

No oppositions information available.

History and Publications

Date	Description
19 May 2026	International Registration in Australia Protected correspondence sent
18 May 2026	International Registration in Australia Protected correspondence sent
18 May 2026	IP Right Registration Published	Trade mark details »
18 May 2026	Status change to Registered/Protected
11 Mar 2026	Application Accepted correspondence sent
10 Mar 2026	Application Accepted correspondence sent
10 Mar 2026	IP Right has been Examined
10 Mar 2026	IP Right Acceptance Published	Trade mark details »
10 Mar 2026	Status change to Accepted
02 Mar 2026	Customer Amendment Made correspondence sent
27 Feb 2026	Amendment to Address for Service Requested
12 Feb 2026	Awaiting examination
12 Feb 2026	Examination expedited
12 Feb 2026	Word and image indexing completed
12 Feb 2026	IP Right Filed Published	Trade mark details »
12 Feb 2026	Status change to Published
12 Feb 2026	Status change to Filed
12 Feb 2026	Application Received
12 Feb 2026	IP right goods and service classes updated	More
	Event description Class Count: 2 Class Numbers:42; 44 Previous details Class Count: 0 Class Numbers: New details Class Count: 2 Class Numbers: 42; 44
12 Feb 2026	IP Right Goods and Services Items updated	More
	Event description Class Number: 44 Previous details New details Class Number: 44 Class Items: Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders.
12 Feb 2026	IP Right Goods and Services Items updated	More
	Event description Class Number: 42 Previous details New details Class Number: 42 Class Items: Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders.
12 Feb 2026	Status change to Received
12 Feb 2026	Trade mark representation updated

Dates

Renewal due: 06 Jan 2036
Registration advertised / published: 18 May 2026
Entered on Register: 18 May 2026
Acceptance advertised / published: 10 Mar 2026
Acceptance: 10 Mar 2026
IR notification: 12 Feb 2026
Filing: 06 Jan 2026
Registered from: 06 Jan 2026

Owner

Address for service

IR Contact

Indexing constituents

Word

AMPAVEGA

AMPA

VEGA

Image

MOLECULAR-DIAGRAM

DOT+

SIX

CIRCLE

ROUND

EXTENDED

STRIPE+

OBLIQUE